Long Term Survivors Archives – Treatment Action Group

Research Toward a Cure Trials

March 15, 2023
Dorrit Walsh

A listing of clinical trials and observational studies related to the research effort to cure HIV infection, mainly derived from the clinicaltrials.gov online registry. Click the trial registry identifier numbers for a link to the full entry containing detailed information on the trial design, enrollment criteria, principal investigators and location(s).

Statement from TAG’s HIV Project on FDA’s Approval of Injectable Pre-Exposure Prophylaxis

December 22, 2021
Dorrit Walsh

Treatment Action Group (TAG) welcomes and celebrates the U.S. Food and Drug Administration’s (FDA) approval of Apretude brand cabotegravir, the first injectable medication for use as pre-exposure prophylaxis (PrEP) to reduce the risk of HIV transmission.

Treatment Action Group Statement on New HIV Remission Case Report at AIDS2020

July 8, 2020
Dorrit Walsh

Yesterday, a widely reported presentation by Ricardo Diaz at the ongoing virtual International AIDS Conference (AIDS2020) disclosed that one out of 30 total participants in an HIV cure-related research trial conducted in Brazil has not experienced an HIV viral load rebound for a little over a year (64.7 weeks) after interrupting antiretroviral therapy (ART).

Webinars

July 6, 2020
Dorrit Walsh

Pre-CROI Community HIV Cure Research Workshop - February 18, 2023 Community HIV clinicians' perceptions of HIV cure-related research in the Northwestern United States - Laurie Sylla, January 24, 2023 Engineering B Cells - Dr. Paula Cannon, RID-HIV Collaboratory, DARE Collaboratory…

Cure-Related Research Resources

February 18, 2020
Chad Cipiti

A resource listing of articles, reports, websites, and ongoing clinical trials related to the research effort to cure HIV infection.

Statement from the ACT NOW:END AIDS Coalition on President Trump’s State of the Union Commitment to Eradicate AIDS

February 5, 2020
Dorrit Walsh

The ACT NOW:END AIDS Coalition, of which TAG is a founding member, released this statement today calling for the administration’s efforts to end the HIV epidemic to be rooted in fact, science, and sensible policies that are consistent with the stated goal of ending HIV.

HIV & Aging

December 17, 2019
Chad Cipiti

A resource listing of articles, reports, websites, and ongoing clinical trials related to HIV and aging.

Clinical Trials for People with Suboptimal Immune Reconstitution Despite HIV Suppression

November 16, 2019
Chad Cipiti

Some individuals who initiate antiretroviral therapy (ART) experience limited recovery of CD4 T cell numbers despite suppression of HIV viral load to undetectable levels. The most common risk factors for this type of discordant response to ART are low CD4 T cell count at the time of starting and older age.

TAG Welcomes HHS Lawsuit Against Gilead; Urges Dramatic Scale-Up of Low-Cost PrEP

November 11, 2019
Dorrit Walsh

Treatment Action Group (TAG) welcomes the U.S. Department of Health and Human Services (HHS) pursuit of a lawsuit against Gilead Sciences, Inc., the manufacturer of Truvada and Descovy, the only two FDA-approved pills for pre-exposure prophlyaxis (PrEP) to prevent HIV.

Eight HIV/AIDS Research, Policy, and Advocacy Organizations File an Amici Curiae Brief in Staley v. Gilead – Background and Next Steps

October 30, 2019
Dorrit Walsh

On October 25, 2019, eight HIV/AIDS research, policy, and advocacy organizations filed an amicus brief in the U.S. District Court, in San Francisco, CA, in support of the plaintiffs in Staley v. Gilead.